Definitive Healthcare (NASDAQ:DH) Receives “Hold” Rating from Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of Definitive Healthcare (NASDAQ:DH) in a research report sent to investors on Thursday,Benzinga reports.

DH has been the subject of several other research reports. Stephens assumed coverage on Definitive Healthcare in a research note on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target for the company. Barclays reaffirmed an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a research note on Monday. Two research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $5.72.

Definitive Healthcare Trading Down 0.8 %

Shares of DH stock opened at $3.95 on Thursday. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The business has a 50-day moving average price of $4.35 and a two-hundred day moving average price of $4.51. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $10.62. The firm has a market cap of $456.30 million, a P/E ratio of -1.27, a price-to-earnings-growth ratio of 3.26 and a beta of 1.41.

Insider Activity

In related news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 14.84% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Point72 DIFC Ltd increased its holdings in Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after purchasing an additional 8,215 shares during the period. Intech Investment Management LLC purchased a new position in shares of Definitive Healthcare during the 3rd quarter worth approximately $55,000. Sanctuary Advisors LLC purchased a new position in shares of Definitive Healthcare during the 2nd quarter worth approximately $85,000. Bleakley Financial Group LLC purchased a new position in shares of Definitive Healthcare during the 3rd quarter worth approximately $74,000. Finally, Glenmede Trust Co. NA grew its holdings in shares of Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after acquiring an additional 5,362 shares during the period. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.